Eagle Pharmaceuticals (EGRX) Stock Chart & Stock Price History $3.19 -0.50 (-13.55%) As of 08/1/2025 02:32 PM Eastern Add Compare Share Share Chart Stock AnalysisChartCompetitorsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock Eagle Pharmaceuticals Stock Price Performance The Eagle Pharmaceuticals (EGRX) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has decreased 30.65%, with a year-to-date return of 538.00%. In the past month, the stock has increased 6.33%, reflecting recent market activity. As of the latest close, Eagle Pharmaceuticals traded at $3.19 with a market cap of $41.43 million and volume of 675 shares. Five years ago, the stock traded at $47.72, representing a 93.32% decrease over that period. At the time, it had a market cap of $634.74 million and a volume of 141,225 shares. Receive EGRX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Eagle Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day PerformanceN/A1 Month Performance+6.33%3 Month Performance+61.93%Year-To-Date Performance+538.00%1 Year Performance-30.65%5 Year Performance-93.32% EGRX Stock Chart for Sunday, August, 3, 2025 EGRX Chart by TradingView Eagle Pharmaceuticals Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization08/01/2025$3.69$3.19-13.55%$3.19$2.10675 shs$41.43 million07/25/2025$3.69$3.69$3.69$3.6914 shs$23.38 million07/24/2025$3.69$3.69$3.69$2.50348 shs$47.92 million07/23/2025$3.69$3.69$3.69$2.50348 shs$47.92 million07/22/2025$3.70$3.69-0.27%$3.69$2.50348 shs$47.92 million07/21/2025$3.70$3.70$3.70$2.501,368 shs$48.05 million07/18/2025$3.69$3.70+0.27%$3.70$2.501,368 shs$48.05 million07/17/2025$3.75$3.69-1.60%$3.69$2.901,332 shs$47.92 million07/16/2025$3.74$3.75+0.27%$3.75$2.601,343 shs$48.70 million07/15/2025$3.74$3.74$3.75$2.607,169 shs$48.57 million Get the Latest News and Ratings for EGRX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Eagle Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 07/14/2025$3.55$3.74+5.35%$3.75$2.607,169 shs$48.57 million07/11/2025$3.55$3.55$3.58$1.9012,073 shs$46.10 million07/10/2025$3.65$3.55-2.74%$3.58$1.9012,073 shs$46.10 million07/09/2025$3.25$3.65+12.31%$3.87$2.9010,754 shs$47.40 million07/08/2025$3.00$3.25+8.33%$3.25$3.00950 shs$42.21 million07/07/2025$3.00$3.00$3.00$2.36620 shs$38.96 million07/04/2025$3.00$3.00$3.00$2.36620 shs$38.96 million07/03/2025$2.90$3.00+3.63%$3.00$2.36620 shs$38.96 million07/02/2025$2.36$2.90+22.67%$3.00$2.40717 shs$37.60 million Related Companies CYBN Stock Price Chart SXTC Stock Price Chart CRBU Stock Price Chart EPRX Stock Price Chart GNFT Stock Price Chart DRUG Stock Price Chart ALMS Stock Price Chart TLSA Stock Price Chart VYGR Stock Price Chart DMAC Stock Price Chart Receive EGRX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Eagle Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:EGRX) was last updated on 8/3/2025 by MarketBeat.com Staff From Our PartnersMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | SponsoredMusk’s Project Colossus could mint millionairesI predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new milliona...Brownstone Research | SponsoredCrypto Income (almost instantly)How would you like to collect a small percentage of the $4 billion changing hands daily in the crypto market? ...Awesomely, LLC | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredTurn $1K into $50K with This DeFi GemBitcoin grabs headlines, but smart money likes this token My research team has identified the token positio...Crypto 101 Media | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | SponsoredEx-Hedge Fund Manager Uncovers $100 Trillion Land ShiftTrump's Radical New Plan Could Enrich Thousands This isn't a campaign stunt. It's a $100 trillion move to u...Stansberry Research | SponsoredTrump’s betrayal exposed Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Eagle Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Eagle Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free EGRX Stock Alerts